Librela-A clinical update
20 Nov 2026
Zoetis Learning Academy
Since its UK launch in 2021, a growing body of real-world experience and published data has helped refine how we use Librela in day-to-day osteoarthritis case management. This session provides a practical, evidence-led clinical update, focusing on what the latest medical data tells us about effectiveness, safety, and patient selection.
- Summarise the latest medical evidence on Librela’s efficacy and safety since 2021 and describe what it means for everyday clinical use.
- Identify appropriate candidates for Librela based on signalment, clinical presentation, comorbidities, and owner goals.
- Supporting conversations with pet owners (timeline to response, follow-up, and quality-of-life goals) to support adherence and shared decision-making.
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
